COULIE BERNARD (President and CEO) sold 15.0% of their position (89.38K shares) of PLIANT THERAPEUTICS, INC. on the open market
Open‑market sale worth $114.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/22/2026ACC: 0001746473-26-000009
DirectorOfficer· President and CEO
Since Jun 2020
-89.38K
Net shares
Net seller
$114.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
89.38K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−89.38K
Price / share
$1.28
Trade value
$114.40K
% of position
15.0%
1/20/2026
594.98K→505.60K
Total
Net shares
−89.38K
Net value
-$114.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/20/2026 | S · Sale | −89.38K | $1.28 | $114.40K | 15.0% | 594.98K | 505.60K |
| Total | −89.38K | -$114.40K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned409.32K
Total
409.32K indirect409.32K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 409.32K | Indirect |
| Total | 409.32K | 409.32K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported